UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055920
Receipt number R000063901
Scientific Title A 12-month single-center, single-arm comparative study on the efficacy and safety of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease
Date of disclosure of the study information 2024/10/23
Last modified on 2024/10/23 13:26:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A 12-month single-center, single-arm comparative study on the efficacy and safety of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease

Acronym

A 12-month study of esophageal rehabilitation for refractory gastroesophageal reflux disease

Scientific Title

A 12-month single-center, single-arm comparative study on the efficacy and safety of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease

Scientific Title:Acronym

A 12-month single-center, single-arm comparative study of esophageal rehabilitation for acid suppressive medication-resistant gastroesophageal reflux disease

Region

Japan


Condition

Condition

gastroesophageal reflux disease

Classification by specialty

Medicine in general Gastroenterology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Alleviation of the symptom of gastro-esophageal reflux disease (GERD)

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The numerical value change of FSSG (Frequency Scale for the Symptoms of GERD) after 12 months' esophageal exercise therapy.

Key secondary outcomes

Changes in FSSG 2-4 weeks, 3 months, and 2 years after starting exercise therapy. Changes in acid suppressive medication intake and endoscopic mucosal lesions 2-4 weeks, 3 months, 1 year, and 2 years after starting exercise therapy. For those who gain consent, pH monitoring (24-hour esophageal pH monitoring or 24-hour esophageal impedance/pH monitoring) and manometry findings.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Swallowing training will be conducted 10 times at 7 to 10 seconds intervals in a supine position with their lower back raised. The program is performed twice a day for 12 months.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with GERD, whose symptom is refractory to conventional therapy including proton-pump inhibitor or vonoprazan and exhibit its FSSG score beyond 7.
Participants will be registered six years after the date of approval of this study.
Informed consent is obtained from all subjects before enrollment in the study.

Key exclusion criteria

Difficulty evaluating their own condition because of dementia or mental disturbance.
Heart or respiratory failure, spinal disease or other poor general condition.
Pregnant women or women who may be pregnant.
Those who are under the control of a randomized study regarding gastroesophageal reflux disease.
Those who are deemed inappropriate by their attending physician.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Tomoko
Middle name
Last name Nishimura

Organization

Nishijin Hospital

Division name

Department of Internal Medicine

Zip code

6028319

Address

1035, Mizomaecho, Kamigyoku, kyoto, Japan.

TEL

0754618800

Email

tnishimura@nishijinhp.com


Public contact

Name of contact person

1st name Tomoko
Middle name
Last name Nishimura

Organization

Nishijin Hospital

Division name

Department of Internal Medicine

Zip code

6028319

Address

1035, Mizomaecho, Kamigyoku, kyoto, Japan.

TEL

0754618800

Homepage URL


Email

tnishimura@nishijinhp.com


Sponsor or person

Institute

Nishijin Hpspital

Institute

Department

Personal name



Funding Source

Organization

Self-Funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nishijin Hospital

Address

1035, Mizomaecho, Kamigyoku, kyoto, Japan.

Tel

0754618800

Email

tnishimura@nishijinhp.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 10 Month 22 Day

Date of IRB

2024 Year 10 Month 22 Day

Anticipated trial start date

2024 Year 10 Month 23 Day

Last follow-up date

2032 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 23 Day

Last modified on

2024 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063901